Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
InChi: InChI=1S/C17H14O3/c1-11-14(18)10-16-13(17(11)19-2)8-9-15(20-16)12-6-4-3-5-7-12/h3-10H
The EC50 value of full P-ERK1/2 activation for Ro 67-7476 are nearly identical to the EC50 for calcium mobilization potentiation
GW5074 could have therapeutic value against neurodegenerative pathologies in humans
InChiKey: WAOBCCBUTHNTFO-UHFFFAOYSA-N
comparable to those required for inhibition of insulin-induced phosphorylation of Akt/PKB
PF-06873600 Size:Contact [email protected] for quotation InChi: InChI=1S/C17H14O3/c1-11-14(18)10-16-13(17(11)19-2)8-9-15(20-16)12-6-4-3-5-7-12/h3-10HPF 06873600 is a selective and orally bioavailable inhibitor of cyclin dependent kinase (CDK), with Ki values of 0. 09 nM, 0. 13 nM and 0. 16 nM for CDK2, CDK4 and CDK6, respectively. PF 06873600 has potential antineoplastic activity. Product information CAS Number: 2185857 97 8 Molecular Weight: 471. 52 Formula: C20H27F2N5O4S Chemical Name: 6 (difluoromethyl) 8 [(1R,2R) 2 hydroxy 2 methylcyclopentyl] 2 [(1 methanesulfonylpiperidin 4 yl)amino] 7H,8H
US$ 129.00
US$ 32.99
US$ 149.00